摘要
目的:探讨临床药师参与乳腺癌合并副肿瘤性小脑变性(paraneoplastic cerebellar degeneration,PCD)患者药物治疗、提供药学服务的实践。方法:临床药师参与1例乳腺癌合并PCD患者药物治疗的全过程,给予药学监护。结果:临床药师初步探讨了PCD患者药学监护的切入点,分析了在其干预下患者2次入院化疗期间用药情况的不同,为临床医师提供了合理的个体化治疗建议。结论:PCD患者的监护特点与普通肿瘤患者不同,应避免使用免疫增强药;此外,结合PCD患者出院带药多的特点,临床药师应做好用药教育及随访工作。通过对该患者的药学实践,临床药师发挥了专业特长,体现了自身价值。
OBJECTIVE: To probe into the pharmaceutical care for patients with breast cancer combined with paraneoplastic cerebellar degeneration( PCD) in drug treatment by the clinical pharmacists. METHODS: The clinical pharmacists participated into the whole process of drug treatment of patients with breast cancer combined with PCD and provided pharmaceutical care. RESULTS: The clinical pharmacists discussed the entry point of pharmaceutical care for patients with breast cancer combined with PCD, analyzed the drug treatment difference of patients with two chemotherapy under the intervention and provided rational individualized treatment recommendations for the clinicians.CONCLUSIONS: The characteristics of pharmaceutical care for patients with PCD are different from general tumor patients,therefore,the immune-enhancing drugs should be prohibited. Besides,the clinical pharmacists should provide education of drug-use and follow up visit for patients. The clinical pharmacists bring their specialty into full play and reflect their own value.
出处
《中国医院用药评价与分析》
2016年第10期1428-1431,共4页
Evaluation and Analysis of Drug-use in Hospitals of China
关键词
副肿瘤综合征
副肿瘤性小脑变性
乳腺癌
药学监护
Paraneoplastic neurological syndrome
Paraneoplastic cerebellar degeneration
Breast cancer
Pharmaceutical care